Synopsis
Motivation:
Goals:
Approach:
Results:
370-04-029
ISMRM Abstract
Iron accumulation in Caudate and its associations with age and sex across hemispheres in Parkinson’s disease
Accepted
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
Log inReferences
1. Simon DK, Tanner CM and Brundin P. Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clin Geriatr Med 2020; 36: 1–12. 20190824. DOI: 10.1016/j.cger.2019.08.002. [doi]
2. Liu Z, Shen HC, Lian TH, et al. Iron deposition in substantia nigra: abnormal iron metabolism, neuroinflammatory mechanism and clinical relevance. Sci Rep 2017; 7: 14973. 20171102. DOI: 10.1038/s41598-017-14721-1. [doi]
3. Du G, Wang E, Sica C, et al. Dynamics of Nigral Iron Accumulation in Parkinson's Disease: From Diagnosis to Late Stage. Mov Disord 2022; 37: 1654–1662. 20220525. DOI: 10.1002/mds.29062. [doi]
4. Yan S, Lu J, Li Y, et al. Spatiotemporal patterns of brain iron-oxygen metabolism in patients with Parkinson's disease. Eur Radiol 2023 20231019. DOI: 10.1007/s00330-023-10283-1. [doi]
5. Dexter DT and Jenner P. Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med 2013; 62: 132–144. 20130204. DOI: 10.1016/j.freeradbiomed.2013.01.018. [doi]
6. Carbon M, Ma Y, Barnes A, et al. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism. NeuroImage 2004; 21: 1497–1507. DOI: https://doi.org/10.1016/j.neuroimage.2003.12.014. [doi]
7. Niethammer M, Tang CC, Ma Y, et al. Parkinson's disease cognitive network correlates with caudate dopamine. Neuroimage 2013; 78: 204–209. 20130408. DOI: 10.1016/j.neuroimage.2013.03.070. [doi]
8. Kermadi I and Joseph JP. Activity in the caudate nucleus of monkey during spatial sequencing. Journal of Neurophysiology 1995; 74: 911–933. DOI: 10.1152/jn.1995.74.3.911. [doi]
9. Lorek K, Mączewska J, Królicki L, et al. Motor cortex activation mediates associations between striatal dopamine depletion and manual dexterity in Parkinson's disease. Parkinsonism & Related Disorders 2024; 125: 107049. DOI: https://doi.org/10.1016/j.parkreldis.2024.107049. [doi]
10. Dexter DT, Carayon A, Javoy-Agid F, et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991; 114 ( Pt 4): 1953–1975. DOI: 10.1093/brain/114.4.1953. [doi]
11. Dexter DT, Wells FR, Lees AJ, et al. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 1989; 52: 1830–1836. DOI: 10.1111/j.1471-4159.1989.tb07264.x. [doi]
12. Du G, Liu T, Lewis MM, et al. Quantitative susceptibility mapping of the midbrain in Parkinson's disease. Mov Disord 2016; 31: 317–324. 20150912. DOI: 10.1002/mds.26417. [doi]
13. Graham JM, Paley MN, Grunewald RA, et al. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 2000; 123 Pt 12: 2423–2431. DOI: 10.1093/brain/123.12.2423. [doi]
14. Oakley AE, Collingwood JF, Dobson J, et al. Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology 2007; 68: 1820–1825. DOI: 10.1212/01.wnl.0000262033.01945.9a. [doi]
15. Zecca L, Youdim MB, Riederer P, et al. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004; 5: 863–873. DOI: 10.1038/nrn1537. [doi]
16. Martin WR, Wieler M and Gee M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 2008; 70: 1411–1417. 20080102. DOI: 10.1212/01.wnl.0000286384.31050.b5. [doi]
17. Zhang J, Liu T, Gupta A, et al. Quantitative mapping of cerebral metabolic rate of oxygen (CMRO2 ) using quantitative susceptibility mapping (QSM). Magn Reson Med 2015; 74: 945–952. 20140926. DOI: 10.1002/mrm.25463. [doi]
18. de Rochefort L, Liu T, Kressler B, et al. Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: Validation and application to brain imaging. Magnetic Resonance in Medicine 2010; 63: 194–206. DOI: https://doi.org/10.1002/mrm.22187. [doi]
19. 19. Wang Y and Liu T. Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker. Magn Reson Med 2015; 73: 82–101. DOI: 10.1002/mrm.25358. [doi]
20. Zhang J, Cho J, Zhou D, et al. Quantitative susceptibility mapping-based cerebral metabolic rate of oxygen mapping with minimum local variance. Magn Reson Med 2018; 79: 172–179. 20170310. DOI: 10.1002/mrm.26657. [doi]
21. Zhang J, Zhou D, Nguyen TD, et al. Cerebral metabolic rate of oxygen (CMRO(2) ) mapping with hyperventilation challenge using quantitative susceptibility mapping (QSM). Magn Reson Med 2017; 77: 1762–1773. 20160427. DOI: 10.1002/mrm.26253. [doi]
22. Ravanfar P, Loi SM, Syeda WT, et al. Systematic Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in Neurodegenerative Diseases. Frontiers in Neuroscience 2021; 15. Systematic Review. DOI: 10.3389/fnins.2021.618435. [doi]
23. Schweser F, Deistung A and Reichenbach JR. Foundations of MRI phase imaging and processing for Quantitative Susceptibility Mapping (QSM). Zeitschrift für medizinische Physik 2016; 26: 6–34.
24. Eskreis‐Winkler S, Zhang Y, Zhang J, et al. The clinical utility of QSM: disease diagnosis, medical management, and surgical planning. NMR in Biomedicine 2017; 30: e3668.
25. Wen Y, Spincemaille P, Nguyen T, et al. Multiecho complex total field inversion method (mcTFI) for improved signal modeling in quantitative susceptibility mapping. Magnetic Resonance in Medicine 2021; 86: 2165–2178. DOI: https://doi.org/10.1002/mrm.28814. [doi]
26. Cho J, Kee Y, Spincemaille P, et al. Cerebral metabolic rate of oxygen (CMRO(2) ) mapping by combining quantitative susceptibility mapping (QSM) and quantitative blood oxygenation level-dependent imaging (qBOLD). Magn Reson Med 2018; 80: 1595–1604. 20180307. DOI: 10.1002/mrm.27135. [doi]
27. Misra A and Cho J. An Optimal, Routinely Applicable Multi-Echo Gradient Echo (mGRE) Data Acquisition Scheme for QQ-based Oxygen Extraction Fraction (OEF) Mapping.
28. Cho J, Zhang S, Kee Y, et al. Cluster analysis of time evolution (CAT) for quantitative susceptibility mapping (QSM) and quantitative blood oxygen level-dependent magnitude (qBOLD)-based oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen (CMRO(2) ) mapping. Magn Reson Med 2020; 83: 844–857. 20190910. DOI: 10.1002/mrm.27967. [doi]
29. Cho J, Spincemaille P, Nguyen TD, et al. Temporal clustering, tissue composition, and total variation for mapping oxygen extraction fraction using QSM and quantitative BOLD. Magn Reson Med 2021; 86: 2635–2646. 20210610. DOI: 10.1002/mrm.28875. [doi]
30. Cho J, Zhang J, Spincemaille P, et al. QQ-NET - using deep learning to solve quantitative susceptibility mapping and quantitative blood oxygen level dependent magnitude (QSM+qBOLD or QQ) based oxygen extraction fraction (OEF) mapping. Magn Reson Med 2022; 87: 1583–1594. 20211031. DOI: 10.1002/mrm.29057. [doi]
31. Hubertus S, Thomas S, Cho J, et al. Using an artificial neural network for fast mapping of the oxygen extraction fraction with combined QSM and quantitative BOLD. Magn Reson Med 2019; 82: 2199–2211. 20190704. DOI: 10.1002/mrm.27882. [doi]
32. Cho J, Zhang J, Spincemaille P, et al. Multi-Echo Complex Quantitative Susceptibility Mapping and Quantitative Blood Oxygen Level-Dependent Magnitude (mcQSM + qBOLD or mcQQ) for Oxygen Extraction Fraction (OEF) Mapping. Bioengineering 2024; 11: 131.
33. Cho J, Lee J, An H, et al. Cerebral oxygen extraction fraction (OEF): Comparison of challenge-free gradient echo QSM+qBOLD (QQ) with (15)O PET in healthy adults. J Cereb Blood Flow Metab 2021; 41: 1658–1668. 20201127. DOI: 10.1177/0271678x20973951. [doi]
34. Cho J, Ma Y, Spincemaille P, et al. Cerebral oxygen extraction fraction: Comparison of dual-gas challenge calibrated BOLD with CBF and challenge-free gradient echo QSM+qBOLD. Magn Reson Med 2021; 85: 953–961. 20200811. DOI: 10.1002/mrm.28447. [doi]
35. Elanghovan P, Nguyen T, Spincemaille P, et al. Sensitivity assessment of QSM+qBOLD (or QQ) in detecting elevated oxygen extraction fraction (OEF) in physiological change. J Cereb Blood Flow Metab 2024: 271678x241298584. 20241105. DOI: 10.1177/0271678x241298584. [doi]
36. Zhang S, Cho J, Nguyen TD, et al. Initial Experience of Challenge-Free MRI-Based Oxygen Extraction Fraction Mapping of Ischemic Stroke at Various Stages: Comparison With Perfusion and Diffusion Mapping. Frontiers in Neuroscience 2020; 14. Original Research. DOI: 10.3389/fnins.2020.535441. [doi]
37. Wu D, Zhou Y, Cho J, et al. The Spatiotemporal Evolution of MRI-Derived Oxygen Extraction Fraction and Perfusion in Ischemic Stroke. Frontiers in Neuroscience 2021; 15. Original Research. DOI: 10.3389/fnins.2021.716031. [doi]
38. Zhang S, Cho J, Nguyen TD, et al. Initial experience using combined quantitative susceptibility mapping and quantitative bold oxygen level dependent imaging (QSM+ qBOLD) oxygen extraction fraction for evaluation of acute ischemic stroke.
39. Cho J, Zhang S, Kee Y, et al. Data-driven regularized inversion (DRI) for improved QSM+ qBOLD based CMRO2 Mapping: a feasibility study in healthy subjects and ischemic stroke patients.
40. Yang L, Cho J, Chen T, et al. Oxygen extraction fraction (OEF) assesses cerebral oxygen metabolism of deep gray matter in patients with pre-eclampsia. European Radiology 2022; 32: 6058–6069. DOI: 10.1007/s00330-022-08713-7. [doi]
41. Zhang Q, Sui C, Cho J, et al. Assessing Cerebral Oxygen Metabolism Changes in Patients With Preeclampsia Using Voxel-Based Morphometry of Oxygen Extraction Fraction Maps in Magnetic Resonance Imaging. Korean J Radiol 2023; 24: 324–337. 20230307. DOI: 10.3348/kjr.2022.0652. [doi]
42. Zhuang H, Cho J, Chiang GC-Y, et al. Cerebral oxygen extraction fraction declines with ventricular enlargement in patients with normal pressure hydrocephalus. Clinical Imaging 2023; 97: 22–27. DOI: https://doi.org/10.1016/j.clinimag.2023.02.001. [doi]
43. Cho J, Nguyen TD, Huang W, et al. Brain oxygen extraction fraction mapping in patients with multiple sclerosis. Journal of Cerebral Blood Flow & Metabolism 2021; 42: 338–348. DOI: 10.1177/0271678X211048031. [doi]
44. Xie Y, Zhang S, Wu D, et al. The changes of oxygen extraction fraction in different types of lesions in relapsing–remitting multiple sclerosis: A cross-sectional and longitudinal study. Neurological Sciences 2024; 45: 3939–3949. DOI: 10.1007/s10072-024-07463-2. [doi]
45. Cho J, Nguyen TD, Huang W, et al. Regional oxygen extract fraction mapping (rOEF) of multiple sclerosis brains.
46. Yan S, Lu J, Li Y, et al. Spatiotemporal patterns of brain iron-oxygen metabolism in patients with Parkinson’s disease. European Radiology 2024; 34: 3074–3083. DOI: 10.1007/s00330-023-10283-1. [doi]
47. Shen N, Zhang S, Cho J, et al. Application of Cluster Analysis of Time Evolution for Magnetic Resonance Imaging -Derived Oxygen Extraction Fraction Mapping: A Promising Strategy for the Genetic Profile Prediction and Grading of Glioma. Frontiers in Neuroscience 2021; 15. Original Research. DOI: 10.3389/fnins.2021.736891. [doi]
48. Hubertus S, Thomas S, Cho J, et al. In MRI-based oxygen extraction fraction and cerebral metabolic rate of oxygen mapping in high-grade glioma using a combined quantitative susceptibility mapping and quantitative blood oxygenation level-dependent approach. Proceedings of the International Society for Magnetic Resonance in Medicine, Montréal, QC, Canada 2019: 11–16.
49. van Grinsven EE, de Leeuw J, Siero JCW, et al. Evaluating Physiological MRI Parameters in Patients with Brain Metastases Undergoing Stereotactic Radiosurgery—A Preliminary Analysis and Case Report. Cancers 15. DOI: 10.3390/cancers15174298. [doi]
50. Wang J, Cho J, Zhang C, et al. Assessment of age-related changes of oxygen extraction fraction in of normal adults using QSM and quantitative BOLD.
51. Wu D, Li Y, Zhang S, et al. Trajectories and sex differences of brain structure, oxygenation and perfusion functions in normal aging. Neuroimage 2024; 302: 120903. 20241024. DOI: 10.1016/j.neuroimage.2024.120903. [doi]
52. Chiang GC, Cho J, Dyke J, et al. Brain oxygen extraction and neural tissue susceptibility are associated with cognitive impairment in older individuals. Journal of Neuroimaging 2022; 32: 697–709. DOI: https://doi.org/10.1111/jon.12990. [doi]
53. Zhang S, Ma J, Wu S, et al. Evaluation of MRI-based brain oxygen extraction fraction mapping in patients with systemic lupus erythematosus. Lupus Science & Medicine 2025; 12: e001522. DOI: 10.1136/lupus-2025-001522. [doi]
54. Misra A, Wang Y, Chiang GC, et al. Oxygen extraction fraction is differently associated with pathological biomarkers in Alzheimer’s Disease and non-Alzheimer’s dementias.
55. Misra A, Oros-Peusquens A-M, Reetz K, et al. Assessing Abnormal Oxygen Extraction Fraction and Neural Tissue Susceptibility in Parkinson's Disease. Available at SSRN 5184105.
56. Zhang R, Lin M, Cho J, et al. Oxygen extraction fraction in small vessel disease: relationship to disease burden and progression. Brain 2025; 148: 1950–1962. DOI: 10.1093/brain/awae383. [doi]
57. Yan S, Lu J, Duan B, et al. Potential separation of multiple system atrophy and Parkinson’s disease by susceptibility-derived components. NeuroImage 2025; 318: 121241. DOI: https://doi.org/10.1016/j.neuroimage.2025.121241. [doi]
58. Vallejos G, Khalil MH, Keyes S, et al. Utilizing Oxygen Extraction Fraction to differentiate Multiple Sclerosis from Non-Multiple Sclerosis Fluid-Attenuated Inversion Recovery White Matter Lesions. In: MULTIPLE SCLEROSIS JOURNAL 2024, pp.933–934. SAGE PUBLICATIONS LTD 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND.
59. Hosseini SA, Servaes S, Therriault J, et al. Quantitative evaluation of oxygen extraction fraction (OEF) in Alzheimer's disease: A correlation with tau and amyloid pathology and cognitive status. Journal of the Neurological Sciences 2023; 455. DOI: 10.1016/j.jns.2023.121101. [doi]
60. Cho J, Lv H, Guo L, et al. Neuroimaging of Brain Structure-Function Coupling Mechanism in Neuropsychiatric Disorders. Frontiers Media SA, 2023.
61. Coleman C and Martin I. Unraveling Parkinson's Disease Neurodegeneration: Does Aging Hold the Clues? J Parkinsons Dis 2022; 12: 2321–2338. DOI: 10.3233/jpd-223363. [doi]
62. Cerri S, Mus L and Blandini F. Parkinson's Disease in Women and Men: What's the Difference? J Parkinsons Dis 2019; 9: 501–515. DOI: 10.3233/jpd-191683. [doi]
63. Zirra A, Rao SC, Bestwick J, et al. Gender Differences in the Prevalence of Parkinson's Disease. Mov Disord Clin Pract 2023; 10: 86–93. 20221114. DOI: 10.1002/mdc3.13584. [doi]
64. Péran P, Cherubini A, Assogna F, et al. Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature. Brain 2010; 133: 3423–3433. DOI: 10.1093/brain/awq212. [doi]
65. Li P, Ensink E, Lang S, et al. Hemispheric asymmetry in the human brain and in Parkinson's disease is linked to divergent epigenetic patterns in neurons. Genome Biol 2020; 21: 61. 20200309. DOI: 10.1186/s13059-020-01960-1. [doi]
66. 66. Fahn S. Unified Parkinson’s Disease Rating Scale; Fahn S, Marsden C, Goldstein M, Calne D, editors. (No Title) 1987: 153.
67. Hoehn MM and Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427–442. DOI: 10.1212/wnl.17.5.427. [doi]
68. Cho J, Kee Y, Spincemaille P, et al. Cerebral metabolic rate of oxygen (CMRO2 ) mapping by combining quantitative susceptibility mapping (QSM) and quantitative blood oxygenation level-dependent imaging (qBOLD). Magn Reson Med 2018; 80: 1595–1604. 2018/03/09. DOI: 10.1002/mrm.27135. [doi]
69. Cho J, Zhang S, Kee Y, et al. Cluster analysis of time evolution (CAT) for quantitative susceptibility mapping (QSM) and quantitative blood oxygen level-dependent magnitude (qBOLD)-based oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen (CMRO2 ) mapping. Magn Reson Med 2020; 83: 844–857. 2019/09/11. DOI: 10.1002/mrm.27967. [doi]
70. Hubertus S, Thomas S, Cho J, et al. Comparison of gradient echo and gradient echo sampling of spin echo sequence for the quantification of the oxygen extraction fraction from a combined quantitative susceptibility mapping and quantitative BOLD (QSM+ qBOLD) approach. Magnetic resonance in medicine 2019; 82: 1491–1503.
71. Liu Z, Spincemaille P, Yao Y, et al. MEDI+0: Morphology enabled dipole inversion with automatic uniform cerebrospinal fluid zero reference for quantitative susceptibility mapping. Magn Reson Med 2018; 79: 2795–2803. 2017/10/13. DOI: 10.1002/mrm.26946. [doi]
72. Ma Y, Mazerolle EL, Cho J, et al. Quantification of brain oxygen extraction fraction using QSM and a hyperoxic challenge. Magn Reson Med 2020; 84: 3271–3285. 20200630. DOI: 10.1002/mrm.28390. [doi]
73. Zhang J, Zhou D, Nguyen TD, et al. Cerebral metabolic rate of oxygen (CMRO2 ) mapping with hyperventilation challenge using quantitative susceptibility mapping (QSM). Magn Reson Med 2017; 77: 1762–1773. 2016/04/28. DOI: 10.1002/mrm.26253. [doi]
74. Ulrich X and Yablonskiy DA. Separation of cellular and BOLD contributions to T2* signal relaxation. Magn Reson Med 2016; 75: 606–615. 2015/03/11. DOI: 10.1002/mrm.25610. [doi]
75. He X, Zhu M and Yablonskiy DA. Validation of oxygen extraction fraction measurement by qBOLD technique. Magn Reson Med 2008; 60: 882–888. DOI: 10.1002/mrm.21719. [doi]
76. Yablonskiy DA, Sukstanskii AL and He X. Blood oxygenation level-dependent (BOLD)-based techniques for the quantification of brain hemodynamic and metabolic properties - theoretical models and experimental approaches. NMR Biomed 2013; 26: 963–986. 20120828. DOI: 10.1002/nbm.2839. [doi]
77. Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002; 33: 341–355. 2002/02/08. DOI: 10.1016/s0896-6273(02)00569-x. [doi]
78. Shulman LM. Is there a connection between estrogen and Parkinson's disease? Parkinsonism & Related Disorders 2002; 8: 289–295. DOI: https://doi.org/10.1016/S1353-8020(02)00014-7. [doi]
79. Kim M, Chang Y, Cho Y, et al. Accelerated increase in ferritin levels during menopausal transition as a marker of metabolic health. Scientific Reports 2025; 15: 29311. DOI: 10.1038/s41598-025-14295-3. [doi]
80. Kim HW, Lee S, Yang JH, et al. Cortical Iron Accumulation as an Imaging Marker for Neurodegeneration in Clinical Cognitive Impairment Spectrum: A Quantitative Susceptibility Mapping Study. Korean J Radiol 2023; 24: 1131–1141. DOI: 10.3348/kjr.2023.0490. [doi]
81. Berg D and Youdim MB. Role of iron in neurodegenerative disorders. Top Magn Reson Imaging 2006; 17: 5–17. DOI: 10.1097/01.rmr.0000245461.90406.ad. [doi]
82. Levi S and Finazzi D. Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms. Frontiers in Pharmacology 2014; Volume 5 - 2014. Review. DOI: 10.3389/fphar.2014.00099. [doi]
83. Pagano G, Ferrara N, Brooks DJ, et al. Age at onset and Parkinson disease phenotype. Neurology 2016; 86: 1400–1407. 20160210. DOI: 10.1212/wnl.0000000000002461. [doi]
84. Raket LL, Oudin Åström D, Norlin JM, et al. Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson’s disease. Scientific Reports 2022; 12: 526. DOI: 10.1038/s41598-021-04356-8. [doi]
85. Wise RM, Wagener A, Fietzek UM, et al. Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders. Neurobiology of Disease 2022; 175: 105920. DOI: https://doi.org/10.1016/j.nbd.2022.105920. [doi]
86. Cools R, Gibbs SE, Miyakawa A, et al. Working memory capacity predicts dopamine synthesis capacity in the human striatum. J Neurosci 2008; 28: 1208–1212. DOI: 10.1523/jneurosci.4475-07.2008. [doi]
87. Wright N, Alhindi A, Millikin C, et al. Elevated caudate connectivity in cognitively normal Parkinson's disease patients. Sci Rep 2020; 10: 17978. 20201021. DOI: 10.1038/s41598-020-75008-6. [doi]
88. Spence H, Mengoa-Fleming S, Sneddon AA, et al. Associations between sex, systemic iron and inflammatory status and subcortical brain iron. bioRxiv 2023: 2023.2008.2022.554249. DOI: 10.1101/2023.08.22.554249. [doi]
Cite this abstract
http://echo.ismrm.org/p/ISMRM2026/370-04-029